Targeting PCSK9: bioinformatics analysis reveals functionally damaging missense variants

Proprotein convertase subtilisin/kexin type 9 (PCSK9) modulates cholesterol homeostasis by targeting low-density lipoprotein receptor (LDLR) for lysosomal degradation. Genetic polymorphisms in PCSK9 can alter its autocatalytic processing, secretion, or binding affinity to LDLR. Reduce binding effici...

Full description

Saved in:
Bibliographic Details
Main Authors: Loo, Keat Wei, Huey, Chyi Loh, Griffiths, Lyn R.
Format: Article
Language:en
Published: Penerbit Universiti Kebangsaan Malaysia 2025
Online Access:http://journalarticle.ukm.my/26543/1/ML%2017.pdf
http://journalarticle.ukm.my/26543/
https://jms.mabjournal.com/index.php/mab/issue/view/69
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1858061951040487424
author Loo, Keat Wei
Huey, Chyi Loh
Griffiths, Lyn R.
author_facet Loo, Keat Wei
Huey, Chyi Loh
Griffiths, Lyn R.
author_sort Loo, Keat Wei
building Tun Sri Lanang Library
collection Institutional Repository
content_provider Universiti Kebangsaan Malaysia
content_source UKM Journal Article Repository
continent Asia
country Malaysia
description Proprotein convertase subtilisin/kexin type 9 (PCSK9) modulates cholesterol homeostasis by targeting low-density lipoprotein receptor (LDLR) for lysosomal degradation. Genetic polymorphisms in PCSK9 can alter its autocatalytic processing, secretion, or binding affinity to LDLR. Reduce binding efficiency between PCSK9 and LDLR leads to elevated low-density lipoprotein cholesterol (LDL-C) level, thereby promoting atherosclerotic plaque formation and increasing the risk of ischemic stroke. The objective of this study was to identify the most functionally significant non-synonymous single-nucleotide polymorphisms (nsSNPs) in PCSK9 via an integrated in silico analysis combining functional prediction tools (PROVEAN, SIFT, PolyPhen-2, SNAP2), protein stability and disease-association predictors, ligand-binding assessment, and post-translational modification analysis. A total of 4,979 PCSK9 variants were retrieved from Ensembl GRCh37/hg19, and HGMD. Functional annotation using PROVEAN, SIFT, PolyPhen-2, and SNAP2 identified 253 nsSNPs, with PolyPhen-2 predicting the largest subset. Upon filtering through the protein stability, disease association, ligand binding, and post-translational modification, five nsSNPs (W156R, H226L, H229R, G337R, and G394V) emerged as the most deleterious, with potential to disrupt secondary autocatalytic processing and significantly impair LDLR-PCSK9 interactions. These findings highlight novel candidate variants that may serve as diagnostic biomarkers and therapeutic targets in dyslipidemia and cardiovascular disease.
format Article
id my-ukm.journal.26543
institution Universiti Kebangsaan Malaysia
language en
publishDate 2025
publisher Penerbit Universiti Kebangsaan Malaysia
record_format eprints
spelling my-ukm.journal.265432026-02-06T01:45:57Z http://journalarticle.ukm.my/26543/ Targeting PCSK9: bioinformatics analysis reveals functionally damaging missense variants Loo, Keat Wei Huey, Chyi Loh Griffiths, Lyn R. Proprotein convertase subtilisin/kexin type 9 (PCSK9) modulates cholesterol homeostasis by targeting low-density lipoprotein receptor (LDLR) for lysosomal degradation. Genetic polymorphisms in PCSK9 can alter its autocatalytic processing, secretion, or binding affinity to LDLR. Reduce binding efficiency between PCSK9 and LDLR leads to elevated low-density lipoprotein cholesterol (LDL-C) level, thereby promoting atherosclerotic plaque formation and increasing the risk of ischemic stroke. The objective of this study was to identify the most functionally significant non-synonymous single-nucleotide polymorphisms (nsSNPs) in PCSK9 via an integrated in silico analysis combining functional prediction tools (PROVEAN, SIFT, PolyPhen-2, SNAP2), protein stability and disease-association predictors, ligand-binding assessment, and post-translational modification analysis. A total of 4,979 PCSK9 variants were retrieved from Ensembl GRCh37/hg19, and HGMD. Functional annotation using PROVEAN, SIFT, PolyPhen-2, and SNAP2 identified 253 nsSNPs, with PolyPhen-2 predicting the largest subset. Upon filtering through the protein stability, disease association, ligand binding, and post-translational modification, five nsSNPs (W156R, H226L, H229R, G337R, and G394V) emerged as the most deleterious, with potential to disrupt secondary autocatalytic processing and significantly impair LDLR-PCSK9 interactions. These findings highlight novel candidate variants that may serve as diagnostic biomarkers and therapeutic targets in dyslipidemia and cardiovascular disease. Penerbit Universiti Kebangsaan Malaysia 2025 Article PeerReviewed application/pdf en http://journalarticle.ukm.my/26543/1/ML%2017.pdf Loo, Keat Wei and Huey, Chyi Loh and Griffiths, Lyn R. (2025) Targeting PCSK9: bioinformatics analysis reveals functionally damaging missense variants. Malaysian Applied Biology, 54 (4). pp. 176-185. ISSN 0126-8643 https://jms.mabjournal.com/index.php/mab/issue/view/69
spellingShingle Loo, Keat Wei
Huey, Chyi Loh
Griffiths, Lyn R.
Targeting PCSK9: bioinformatics analysis reveals functionally damaging missense variants
title Targeting PCSK9: bioinformatics analysis reveals functionally damaging missense variants
title_full Targeting PCSK9: bioinformatics analysis reveals functionally damaging missense variants
title_fullStr Targeting PCSK9: bioinformatics analysis reveals functionally damaging missense variants
title_full_unstemmed Targeting PCSK9: bioinformatics analysis reveals functionally damaging missense variants
title_short Targeting PCSK9: bioinformatics analysis reveals functionally damaging missense variants
title_sort targeting pcsk9: bioinformatics analysis reveals functionally damaging missense variants
url http://journalarticle.ukm.my/26543/1/ML%2017.pdf
http://journalarticle.ukm.my/26543/
https://jms.mabjournal.com/index.php/mab/issue/view/69
url_provider http://journalarticle.ukm.my/